Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $207.98, with a market capitalization of 29.53B. The stock trades at a price-to-earnings (P/E) ratio of -135.34.
On 2026-04-04, Natera(NTRA) stock traded between a low of $198.02 and a high of $210.99. Shares are currently priced at $207.98, which is +5.0% above the low and -1.4% below the high.
Natera(NTRA) shares are trading with a volume of 1.27M, against a daily average of 1.14M.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.
NTRA News
Advertisement Why the latest Signatera study matters for Natera (NTRA) shareholders Natera (NTRA) is back in focus after publishing new Clinical Cancer Resear...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context,...
Analyst ratings
90%
of 21 ratingsMore NTRA News
Natera, Inc. recently reported Clinical Cancer Research data showing its Signatera molecular residual disease test helped older women with early-stage ER+/HER2-...
• Natera stock is showing exceptional strength. What’s fueling NTRA momentum? Signatera Study: MRD-Negative Patients Skip Surgery The study published in Clinica...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.